GoldenGolden
Advanced Search
Nextbiotics

Nextbiotics

Nextbiotics is a biotechnology and synthetic biology company that leverages synthetic biology tools and bacteriophage technology to provide solutions to the antibiotic resistance crisis.

Nextbiotics is a biotechnology and synthetic biology company headquartered in San Francisco, California that was founded in 2017 by Angie Carrillo, Jorge Bardales, an Maricel Saenz.

The company combines bacteriophage therapy (Phage therapy) with CRISPR technology to reverse antibiotic resistance.The engineered viruses will specifically target drug-resistant bacteria and generate double-strand breaks, destroying the drug resistant genes or the genomic DNA of the bacteria, which will kill the bacteria.

One of the founders, Dr. Jorge Bardales, has a Ph.D. in Biophysics from University of California Berkeley and worked in the lab of Jennifer Doudna, one of the original group of scientists that developed CRISPR as a biotechnology tool.

Funding
Seed

On January 26, 2018 Nextbiotics completed their seed funding round with $100,000 in funding from Berkeley SkyDeck Fund.

Timeline

January 26, 2018
Seed

On January 26, 2018 Nextbiotics completed their seed funding round with $100,000 in funding from Berkeley SkyDeck Fund.

July 2017
Nextbiotics was founded by Angie Carrillo Reluz and Maricel Saenz.

Funding rounds

People

Name
Role
LinkedIn

Angie Carrillo

Founder

Angie Carrillo Reluz

Founder

Jorge Bardales

Founder

Maricel Saenz

Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Global Solutions Program: NextBiotics | Maricel Saenz | SU Global Summit

October 5, 2007

Nextbiotics SU Global Summit 2017

August 22, 2017

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.